INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 427m ago
HOUSE PTR27m ago
SEC 13F27m ago
ROBINHOOD CHAIN27m ago
Corporate insider
DM

Dube Eric M

Director, CHIEF EXECUTIVE OFFICERCIK 0001763494

EDGAR filingsOpen in network
Disclosed transactions21
Buys / sells0 / 9
Max Insider Score29
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
43.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Travere Therapeutics, Inc.Director, CHIEF EXECUTIVE OFFICER · Jan 27, 2026
0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M
—
200.0K sh
Oct 15, 2026
Oct 19, 2026
traded Oct 15, 2026
+4d
SEC FORM 4

Evidence

9
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$1.79M
200.0K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

11
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$6.78M
128.1K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

11
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$2.02M
37.3K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

11
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$4.31M
78.4K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

5
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$1.18M
43.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
22.5K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
22.5K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Grant or award · 10b5-1 plan
A—
45.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

22
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$989K
22.5K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC FORM 4

Evidence

22
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$299K
7,165 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC FORM 4

Evidence

29
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$2.33M
56.8K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC FORM 4

Evidence

16
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$853
20 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC FORM 4

Evidence

0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Grant or award · 10b5-1 plan
A—
64.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

5
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$802K
51.9K sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC FORM 4

Evidence

24
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.56M
51.9K sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC FORM 4

Evidence

0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
8,135 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC FORM 4

Evidence

7
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
51.9K sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC FORM 4

Evidence

2
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$126K
8,135 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC FORM 4

Evidence

18
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$244K
8,135 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC FORM 4

Evidence